Navigation Links


USDM Life Sciences Names Holger Braemer, Vice President of EU and UK Division and Managing Director of USDM Europe GmbH in Germany

4/20/2017
SANTA BARBARA, CALIFORNIA (PRWEB) April 20, 2017 USDM Life Sciences , the leading risk management, technological innovation and business process optimization firm for the life sciences and healthcare industries, is pleased to announce Holger Braemer as Vice President of its Europe division... [Comments]

Student and Faculty Scholarship to be Celebrated During Husson University’s Eighth Annual Research and Scholarship Day

4/20/2017
Bangor, Maine (PRWEB) April 20, 2017 Husson University will be celebrating students and faculty members’ contributions to the scientific and clinical research community’s growing body of knowledge during its Eighth Annual Research and Scholarship Day on Thursday, April 20, 2017 in the Graci... [Comments]

NetDimensions Welcomes Bill Mastin as SVP, Global Sales

4/20/2017
Hong Kong (PRWEB) April 20, 2017 NetDimensions appoints Bill Mastin, a learning technology veteran, as its new Senior Vice President for Global Sales. With over 20 years of experience in the learning technologies industry, Mastin joins NetDimensions from the New York office of learning and... [Comments]

Prometic's PBI-4050 Shown to Reduce Liver Damage and Fibrosis in High-Fat Diet Induced Obesity and Metabolic Syndrome Mouse Model

4/20/2017
LAVAL, QC , April 20, 2017 /PRNewswire/ - Prometic Life Sciences Inc. (TSX: PLI) (OTCQX: PFSCF) ("Prometic" or the "Corporation") today presented new results at the International Liver Congress ("ILC") 2017 of the European Association for the Study of the Liver ("EASL") in Amsterdam on the positive effects of PBI-4050 on reduction of non-alcoholic steatohepatitis (NASH) in a mouse mo... [Comments]

Energetiq CEO Debbie Gustafson Appointed to SEMI North America Advisory Board

4/20/2017
Woburn, MA (PRWEB) April 20, 2017 Energetiq Technology , a world leader in high brightness light sources for advanced technology applications, announced today that Chief Executive Officer (CEO) Debbie Gustafson has been appointed to the SEMI North America Advisory Board (NAAB). SEMI is... [Comments]

Parallel6 Named One of the 2017 Top 10 eClinical Trial Management Solution Providers by Pharma Tech Outlook

4/20/2017
San Diego, CA (PRWEB) April 20, 2017 Parallel6™ , the leader in mClinical™ technologies for improving patient enrollment, engagement, and management of clinical trials worldwide, announced today that they were named one of the 2017 Top 10 eClinical Trial Management Solution Providers by Pha... [Comments]

Open Therapeutics and the Center for Advancing Innovation Form Partnership

4/20/2017
Minneapolis, MN and Bethesda, MD (PRWEB) April 20, 2017 Open Therapeutics and the Center for Advancing Innovation announce the formation of a unique intellectual property (IP) sharing and commercialization model. The Center for Advancing Innovation helps institutions maximize the commercia... [Comments]

Dutch Philosopher Koert van Mensvoort, Founder of the Next Nature Network, Writes a Letter to Humanity

4/20/2017
AMSTERDAM , April 20, 2017 Dutch philosopher Koert van Mensvoort - founder of the Next Nature Network and Fellow of 'Next Nature' at the University of Technology in Eindhoven - has written a 'Letter to Humanity' in support of International Earth Day. In this letter, he calls on humanity to avoid becoming a slave and victim to its own technology, but to employ technology... [Comments]

Brainstorm Cell Therapeutics to Present at ARM's 5th Annual Cell & Gene Therapy Investor Day, April 27 in Boston

4/20/2017
HACKENSACK, N.J. and PETACH TIKVAH, Israel , April 20, 2017  BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, announced today that Chaim Lebovits , Chief Executive Officer, will present at the Alliance for Regenerative Medicine's (ARM) 5 th Annual Cell & Gene Therapy Investor Day... [Comments]

Biotech Stocks Under Scanner -- Biostage, Keryx Biopharma, Kite Pharma, and ZIOPHARM Oncology

4/20/2017
NEW YORK , April 20, 2017 For today, Stock-Callers.com redirects investors' attention to Biotechnology, an industry that focuses on novel drug development and clinical research aimed at treating diseases and medical conditions. Under evaluation this morning are: Biostage Inc. (NASDAQ: BSTG), Keryx Biopharmaceuticals Inc. (NASDAQ: KERX), Kite Pharma Inc. (NASDAQ: KITE), and Z... [Comments]

[previous] [next]
(Date:4/11/2017)... 11, 2017 NXT-ID, Inc. (NASDAQ:   ... announces the appointment of independent Directors Mr. Robin D. ... Board of Directors, furthering the company,s corporate governance and expertise. ... Gino Pereira , ... forward to their guidance and benefiting from their considerable expertise ...
(Date:4/5/2017)... 2017  The Allen Institute for Cell Science today ... one-of-a-kind portal and dynamic digital window into the human ... first application of deep learning to create predictive models ... and a growing suite of powerful tools. The Allen ... future publicly available resources created and shared by the ...
(Date:4/5/2017)... 4, 2017 KEY FINDINGS The ... at a CAGR of 25.76% during the forecast period ... primary factor for the growth of the stem cell ... MARKET INSIGHTS The global stem cell market ... and geography. The stem cell market of the product ...
Breaking Biology News(10 mins):
Comp Dim: chamber diam. depth 20 2.8 mm chamber maximum volume 720 μL...
... Designed for in vitro diagnostic assays, ... medical-grade polystyrene for uniform binding, high optical ... the Easy-Washproducts are part of the Certified ... performance to be within QA release specifications. ...
... clarification reagent; Ideal for clarifying many ... proteins, nucleic acids, & proteoglycans; Contains ... improves downstream processing; Utilizes a reagent ... supplied as a suspension in saline; ...
... lyophilization stabilizer is designed to stabilize ... for long-term storage. There are ... It is a convenient 10 ... and is superior to other traditional ...
Biology Products:
(Date:4/20/2017)... YORK , April 20, 2017 ... that focuses on novel drug development and clinical research aimed ... are: Biostage Inc. (NASDAQ: BSTG), Keryx Biopharmaceuticals Inc. (NASDAQ: KERX), ... ZIOP ). You can access our complimentary research ... ...
(Date:4/19/2017)... ... April 18, 2017 , ... Optofluidics today announced that it's ... the company changed focus to making analytical tools for biopharmaceutical quality control. “We ... says CEO Robert Hart. Founders Bernardo Cordovez, Robert Hart and David Erickson have ...
(Date:4/19/2017)... ... 19, 2017 , ... As part of the Stago ... as well as experienced users, attendees will gain a better understanding of the ... , Hemostasis testing quality is determined by preanalytical variables which encompass patient preparation, ...
(Date:4/19/2017)... Calif. , April 19, 2017 ... ) today announced that it will report its ... market on Wednesday, May 3, 2017. Following the announcement, Veracyte,s management ... at 4:30 p.m. Eastern Time to discuss the company,s financial ... webcast and subsequent replay may be accessed by ...
Breaking Biology Technology: